Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Casey, Patricia R.
Tyrer, Peter J.
and
Platt, Stephen
1985.
The relationship between social functioning and psychiatric symptomatology in primary care.
Social Psychiatry,
Vol. 20,
Issue. 1,
p.
5.
Curson, D A
Hirsch, S R
Platt, S D
Bamber, R W
and
Barnes, T R
1986.
Does short term placebo treatment of chronic schizophrenia produce long term harm?.
BMJ,
Vol. 293,
Issue. 6549,
p.
726.
Laporte, Joan-Ramon
and
Capellà, Dolors
1987.
Vol. 11,
Issue. ,
p.
44.
Demisch, L.
and
Gerbaldo, H.
1988.
Biologische Psychiatrie.
p.
126.
Craig, Ashley R.
1989.
In Defence of Smooth Speech Treatments: A Response to Onslow and Ingham's Paper “Whither Prolonged Speech? The Disquieting Evolution of a Stuttering Therapy Procedure”.
Australian Journal of Human Communication Disorders,
Vol. 17,
Issue. 2,
p.
61.
Crammer, John
and
Eccleston, Donald
1989.
A survey of the use of depot neuroleptics in a whole region.
Psychiatric Bulletin,
Vol. 13,
Issue. 9,
p.
517.
Pan, P.‐C.
and
Tantam, D.
1989.
Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic.
Acta Psychiatrica Scandinavica,
Vol. 79,
Issue. 6,
p.
564.
Barnes, T. R. E.
and
Hirsch, S. R.
1991.
Guidelines for Neuroleptic Relapse Prevention in Schizophrenia.
p.
16.
Kitamura, Toshinori
and
Suga, Ryoichi
1991.
Depressive and negative symptoms in major psychiatric disorders.
Comprehensive Psychiatry,
Vol. 32,
Issue. 1,
p.
88.
Soni, S. D.
Bamrah, J. S.
and
Krska, J.
1991.
Effects of alcohol on serum fluphenazine levels in stable chronic schizophrenics.
Human Psychopharmacology: Clinical and Experimental,
Vol. 6,
Issue. 4,
p.
301.
Soni, S. D.
and
Brownlee, M.
1991.
Alcohol abuse in chronic schizophrenics: implications for management in the community.
Acta Psychiatrica Scandinavica,
Vol. 84,
Issue. 3,
p.
272.
Sampath, G.
Shah, A.
Krska, J.
and
Soni, S. D.
1992.
Neuroleptic discontinuation in the very stable schizophrenic patient: Relapse rates and serum neuroleptic levels.
Human Psychopharmacology: Clinical and Experimental,
Vol. 7,
Issue. 4,
p.
255.
Hoencamp, E.
Haffmans, P. M. J.
and
Jansen, G. S. I. M.
1992.
Rückfallprophylaxe schizophrener Erkrankungen.
Vol. 3,
Issue. ,
p.
33.
Piatkowska, Olga
and
Farnill, Doug
1992.
Schizophrenia.
p.
339.
Ventura, Joseph
Nuechterlein, Keith H.
Hardesty, Jean Pederson
and
Gitlin, Michael
1992.
Life Events and Schizophrenic Relapse after Withdrawal of Medication.
British Journal of Psychiatry,
Vol. 161,
Issue. 5,
p.
615.
König, P.
Hinterhuber, H.
Haring, Ch.
Schöny, W.
Rittmannsberger, H.
Möller, H.-J.
Katschnig, H.
Konieczna, T.
and
Etzersdorfer, E.
1992.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
81.
Soni, S. D.
Sampath, G.
Shah, A.
and
Krska, J.
1992.
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Acta Psychiatrica Scandinavica,
Vol. 85,
Issue. 5,
p.
354.
Birchwood, Max
and
Shepherd, Geoff
1992.
Controversies and Growing Points in Cognitive-Behavioural interventions for People with Schizophrenia.
Behavioural and Cognitive Psychotherapy,
Vol. 20,
Issue. 4,
p.
305.
Hirsch, Steven R.
1993.
Antipsychotic Drugs and their Side-Effects.
p.
147.
Wohlfarth, Tamar D.
Van Den Brink, Wim
Ormel, Johan
Koeter, Maarten W. J.
and
Oldehinkel, Albertine J.
1993.
The Relationship Between Social Dysfunctioning and Psychopathology among Primary Care Attenders.
British Journal of Psychiatry,
Vol. 163,
Issue. 1,
p.
37.
eLetters
No eLetters have been published for this article.